INTERNATIONAL PATENT: CDR-LIFE AG FILES APPLICATION FOR "ANTIGEN BINDING PROTEINS TARGETING AN HLA-RESTRICTED KK-LC-1 PEPTIDE"

GENEVA, Oct. 13 -- CDR-LIFE AG (Todistrasse 468810 Horgen) filed a patent application (PCT/EP2025/059178) for "ANTIGEN BINDING PROTEINS TARGETING AN HLA-RESTRICTED KK-LC-1 PEPTIDE" on Apr 03, 2025. With publication no. WO/2025/210181, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHEIFELE, Fabian Bert (c/o CDR-LIFE AGTodistrasse 468810 Horgen), SOBIERAJ, Anna Maria (c/o CDR-LIFE AGTodistrasse 468810 Horgen), ALIJAJ, Nagjie Laila (c/o CDR-LIFE AGTodistrasse 468810 Horgen), JUNGMICHEL, Stephanie (c/o CDR-LIFE AGTodistras...